泰林生物收盘下跌1.42%，滚动市盈率267.97倍，总市值28.69亿元

Core Viewpoint - TaiLin Bio's stock closed at 23.67 yuan, down 1.42%, with a rolling PE ratio of 267.97 times, indicating a significant premium compared to the industry average [1] Company Overview - Zhejiang TaiLin Biological Technology Co., Ltd. specializes in microbial testing and pollution control, innovative drug research and production, and process analysis, providing high-quality products and solutions for various industries including biomedicine, healthcare, food and beverage, and environmental protection [2] - The company's main products include a wide range of microbiological testing and control instruments, such as bacterial collection devices, microbial inspection instruments, and various disinfection systems [2] Financial Performance - In the first quarter of 2025, TaiLin Bio reported operating revenue of 66.94 million yuan, a year-on-year decrease of 16.33%, and a net profit of 3.53 million yuan, down 39.93%, with a gross profit margin of 49.27% [2] Market Position - TaiLin Bio's PE ratio of 267.97 times places it significantly above the industry average of 54.79 times and the median of 37.86 times, ranking it 118th in the industry [1][3] - The total market capitalization of TaiLin Bio is 2.869 billion yuan [1]